APP-102
Rare Metabolic Disease
Pre-clinicalDiscovery
Key Facts
About Advanced Protein Production
Advanced Protein Production focuses on overcoming the technical hurdles associated with producing high-value, difficult-to-express proteins, including antibodies, enzymes, and membrane proteins. Its core technology platform aims to increase yields, improve stability, and ensure proper folding of biologics, which are critical for advancing novel therapeutics. The company operates through a hybrid business model, advancing its own preclinical pipeline while offering contract development and manufacturing services. Its strategic direction involves leveraging its platform to forge partnerships with larger biopharma companies and progress its most promising internal candidates toward clinical development.
View full company profileTherapeutic Areas
Other Rare Metabolic Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| AP-501 | Advance Pharmaceutical | Preclinical |